Tau is traditionally recognized as a microtubule-binding protein and has gained significant notoriety because it comprises hallmark pathological lesions in a group of diseases known as tauopathies, including Alzheimer’s disease (AD). The gene discussed is MAPT; the disease is tauopathy.